13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q4 2016. See the latest, Q3 2026 →
Reported value
$7.67B
+9.0% on the quarter before
Positions
44
13 new, 13 sold out
Top 10
71.7%
of the value
Est. gain
+$83.0M
on stocks held all quarter
Est. return
+1.4%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, sized at quarter-end prices.
- Allergan Plc~$300.4MAdded, 6.6% → 9.4% of the portfolio+1,430,625 shares
- Twenty First Centy Fox Inc~$179.2MAdded, 4.4% → 7.0% of the portfolio+6,391,000 shares
- Mckesson Corp~$140.4MNew, 0.0% → 1.8% of the portfolio+1,000,000 shares
- Northstar Rlty Fin Corp~$137.5MAdded, 1.0% → 2.9% of the portfolio+9,078,873 shares
- Northstar Asset Mgmt Group I~$131.2MAdded, 1.8% → 3.6% of the portfolio+8,791,346 shares
- Synchrony Finl~$112.4MAdded, 7.0% → 9.8% of the portfolio+3,100,000 shares
- Viasat Inc~$107.6MAdded, 12.2% → 11.4% of the portfolio+1,625,000 shares
- Cardinal Health Inc~$74.1MNew, 0.0% → 1.0% of the portfolio+1,030,000 shares
- Theravance Biopharma Inc~$61.3MAdded, 3.8% → 3.9% of the portfolio+1,923,000 shares
- Syngenta Ag~$58.9MNew, 0.0% → 0.8% of the portfolio+745,136 shares
Largest sells
Since Q3 2016, sized at quarter-end prices.
- Cheniere Energy Inc~$253.4MCut, 17.3% → 11.7% of the portfolio−6,116,617 shares
- PayPal~$204.8MSold out, 2.9% → 0.0% of the portfolio−5,000,000 shares
- Olin Corp~$126.8MSold out, 1.8% → 0.0% of the portfolio−6,181,302 shares
- Vmware Inc~$117.6MSold out, 1.7% → 0.0% of the portfolio−1,603,889 shares
- Liberty Interactive Corp~$98.5MSold out, 1.4% → 0.0% of the portfolio−2,469,533 shares
- Chipmos Tech Bermuda Ltd~$74.3MSold out, 1.1% → 0.0% of the portfolio−3,751,853 shares
- Klx Inc~$70.4MSold out, 1.0% → 0.0% of the portfolio−2,000,000 shares
- Silver Run Acquisition Corp~$59.1MSold out, 0.8% → 0.0% of the portfolio−3,750,000 shares
- Office Depot Inc~$46.4MSold out, 0.7% → 0.0% of the portfolio−13,000,000 shares
- Cascadian Therapeutics Inc~$41.0MSold out, 0.6% → 0.0% of the portfolio−25,000,000 shares
Holdings
As of Dec 31, 2016; changes in shares since Sep 30, 2016.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cheniere Energy IncCOM NEW · shares −22% · price −5.0% | 11.7% | $900.1M | −$47.1M | ||||||
| Viasat IncCOM · shares +14% · price −11.3% | 11.4% | $871.3M | −$97.2M | ||||||
| Synchrony FinlCOM · shares +18% · price +29.5% | 9.8% | $749.5M | +$145.3M | ||||||
| Allergan PlcSHS · shares +71% · price −8.8% | 9.4% | $720.9M | −$40.6M | ||||||
| Twenty First Centy Fox IncCL A · shares +50% · price +15.8% | 7.0% | $536.6M | +$48.7M | ||||||
| Pbf Energy IncCL A · shares 0% · price +23.1% | 5.7% | $438.4M | +$82.4M | ||||||
| Dell Technologies IncCOM CL V · shares 0% · price +15.0% | 4.8% | $365.7M | +$47.7M | ||||||
| Antero Res CorpCOM · shares 0% · price −12.2% | 4.5% | $343.1M | −$47.9M | ||||||
| Theravance Biopharma IncCOM · shares +26% · price −12.0% | 3.9% | $295.7M | −$32.1M | ||||||
| Northstar Asset Mgmt Group ICOM · shares +89% · price +15.4% | 3.6% | $279.1M | +$19.7M | ||||||
| Northstar Rlty Fin CorpCOM · shares +165% · price +15.0% | 2.9% | $220.8M | +$10.9M | ||||||
| Twenty First Centy Fox IncCL B · shares 0% · price +10.1% | 2.6% | $198.3M | +$18.3M | ||||||
| Veritiv CorpCOM · shares 0% · price +7.1% | 2.1% | $163.6M | +$10.9M | ||||||
| Innoviva IncCOM · shares 0% · price −2.6% | 2.1% | $159.8M | −$4.3M | ||||||
| Keryx Biopharmaceuticals IncCOM · shares 0% · price +10.4% | 2.0% | $151.1M | +$14.2M | ||||||
| Colony Cap IncCL A · shares +57% · price +11.1% | 1.8% | $140.9M | +$9.0M | ||||||
| Mckesson CorpCOM · shares New | 1.8% | $140.4M | — | ||||||
| Forward Pharma A/SSPONSORED ADR · shares 0% · price −28.5% | 1.0% | $80.5M | −$32.2M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price −33.6% | 0.99% | $76.1M | −$38.5M | ||||||
| Cardinal Health IncCOM · shares New | 0.97% | $74.1M | — | ||||||
| Liberty Media Corp DelawareCOM C BRAVES GRP · shares 0% · price +18.5% | 0.80% | $61.6M | +$9.6M | ||||||
| American Intl Group Inc*W EXP 01/19/202 · shares 0% · price +10.7% | 0.79% | $60.9M | +$5.9M | ||||||
| Syngenta AgSPONSORED ADR · shares New | 0.77% | $58.9M | — | ||||||
| Liberty Interactive CorpLBT VEN COM A NE · shares New | 0.71% | $54.6M | — | ||||||
| Credit Accep Corp MichCOM · shares +144% · price +8.2% | 0.69% | $53.2M | +$1.6M | ||||||
| Total 44 positions | 100% | $7.67B | +$83.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 30 stocks held throughout, up $83.0M (+1.4%).
- Synchrony Finl+$145.3M+30%
- Pbf Energy Inc+$82.4M+23%
- Twenty First Centy Fox Inc+$48.7M+16%
- Dell Technologies Inc+$47.7M+15%
- Northstar Asset Mgmt Group I+$19.7M+15%
- Atara Biotherapeutics Inc−$38.5M−34%
- Allergan Plc−$40.6M−9%
- Cheniere Energy Inc−$47.1M−5%
- Antero Res Corp−$47.9M−12%
- Viasat Inc−$97.2M−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |